Author: RxCommercial Research International Inc.Publisher: RxCommercial
ISBN: 1937633063
Category : Business & Economics
Languages : en
Pages : 315
Book Description
Commercialization of Pharmaceutical Products in the USA (Color)
Author: RxCommercial Research International Inc.Publisher: RxCommercial
ISBN: 1937633063
Category : Business & Economics
Languages : en
Pages : 315
Book Description
White Market Drugs
Author: David HerzbergPublisher: University of Chicago Press
ISBN: 022673191X
Category : History
Languages : en
Pages : 372
Book Description
The contemporary opioid crisis is widely seen as new and unprecedented. Not so. It is merely the latest in a long series of drug crises stretching back over a century. In White Market Drugs, David Herzberg explores these crises and the drugs that fueled them, from Bayer’s Heroin to Purdue’s OxyContin and all the drugs in between: barbiturate “goof balls,” amphetamine “thrill pills,” the “love drug” Quaalude, and more. As Herzberg argues, the vast majority of American experiences with drugs and addiction have taken place within what he calls “white markets,” where legal drugs called medicines are sold to a largely white clientele. These markets are widely acknowledged but no one has explained how they became so central to the medical system in a nation famous for its “drug wars”—until now. Drawing from federal, state, industry, and medical archives alongside a wealth of published sources, Herzberg re-connects America’s divided drug history, telling the whole story for the first time. He reveals that the driving question for policymakers has never been how to prohibit the use of addictive drugs, but how to ensure their availability in medical contexts, where profitability often outweighs public safety. Access to white markets was thus a double-edged sword for socially privileged consumers, even as communities of color faced exclusion and punitive drug prohibition. To counter this no-win setup, Herzberg advocates for a consumer protection approach that robustly regulates all drug markets to minimize risks while maintaining safe, reliable access (and treatment) for people with addiction. Accomplishing this requires rethinking a drug/medicine divide born a century ago that, unlike most policies of that racially segregated era, has somehow survived relatively unscathed into the twenty-first century. By showing how the twenty-first-century opioid crisis is only the most recent in a long history of similar crises of addiction to pharmaceuticals, Herzberg forces us to rethink our most basic ideas about drug policy and addiction itself—ideas that have been failing us catastrophically for over a century.
Approved Prescription Drug Products
Author: Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 16
Book Description
Accompanied by supplements.
Dietary Supplements
Author: United States. Federal Trade Commission. Bureau of Consumer ProtectionPublisher:
ISBN:
Category : Advertising
Languages : en
Pages : 32
Book Description
Commercial Relations of the United States with Foreign Countries
Author: United States. Bureau of Foreign and Domestic CommercePublisher:
ISBN:
Category : Commerce
Languages : en
Pages : 284
Book Description
Commercial Relations of the United States with Foreign Countries
Author: United States. Bureau of Foreign Commerce (1854-1903)Publisher:
ISBN:
Category : Commerce
Languages : en
Pages : 696
Book Description
Commercial Relations of the United States with Foreign Countries
Author: United States. Department of Commerce and Labor. Bureau of StatisticsPublisher:
ISBN:
Category : Commerce
Languages : en
Pages : 1298
Book Description
Commercial Relations of the United States with Foreign Countries During the Years ...
Author: Report Upon the Commercial Relations of the United States with Foreign Countries
Author: United States. Bureau of Foreign and Domestic CommercePublisher:
ISBN:
Category : Commerce
Languages : en
Pages : 696
Book Description
Innovation and Marketing in the Pharmaceutical Industry
Author: Min DingPublisher: Springer Science & Business Media
ISBN: 1461478014
Category : Medical
Languages : en
Pages : 763
Book Description
The pharmaceutical industry is one of today’s most dynamic and complex industries, involving commercialization of cutting-edge scientific research, a huge web of stakeholders (from investors to doctors), multi-stage supply chains, fierce competition in the race to market, and a challenging regulatory environment. The stakes are high, with each new product raising the prospect of spectacular success—or failure. Worldwide revenues are approaching $1 trillion; in the U.S. alone, marketing for pharmaceutical products is, itself, a multi-billion dollar industry. In this volume, the editors showcase contributions from experts around the world to capture the state of the art in research, analysis, and practice, and covering the full spectrum of topics relating to innovation and marketing, including R&D, promotion, pricing, branding, competitive strategy, and portfolio management. Chapters include such features as: · An extensive literature review, including coverage of research from fields other than marketing · an overview of how practitioners have addressed the topic · introduction of relevant analytical tools, such as statistics and ethnographic studies · suggestions for further research by scholars and students The result is a comprehensive, state-of-the-art resource that will be of interest to researchers, policymakers, and practitioners, alike.